tiprankstipranks
Trending News
More News >
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market

Compare Keros Therapeutics (KROS) vs. Competitors

Compare
359 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Keros Therapeutics
$18.05
$549.91M
11.70
64.09%
3 Buy
3 Hold
0 Sell
Moderate Buy
Gyre Therapeutics
$6.81
$706.22M
203.94
-34.60%
2 Buy
0 Hold
0 Sell
Moderate Buy
KalVista Pharmaceuticals
$14.98
$757.18M
-3.75
53.64%
8 Buy
0 Hold
0 Sell
Strong Buy
Palvella Therapeutics
$82.01
$970.71M
-6.50
490.42%
15 Buy
0 Hold
0 Sell
Strong Buy
Nurix Therapeutics
$16.55
$1.70B
-5.44
-10.97%
14 Buy
0 Hold
0 Sell
Strong Buy
Bicara Therapeutics Inc.
$16.37
$896.78M
-7.34
33.74%
9 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KROS
Keros Therapeutics
18.05
6.92
62.17%
GYRE
Gyre Therapeutics
7.77
-5.05
-39.39%
KALV
KalVista Pharmaceuticals
14.98
5.08
51.31%
PVLA
Palvella Therapeutics
82.01
67.25
455.62%
NRIX
Nurix Therapeutics
16.55
-2.65
-13.80%
BCAX
Bicara Therapeutics Inc.
16.37
3.65
28.69%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts